Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesWound CareBCBS Arizona skin substitutes Coverage & Prior Aut…
    Ask Trek AI about this page
    Currentblue cross blue shield - arizonaPolicy N/A

    Preferred skin substitute products (coverage and prior authorization)

    Customize your policy alerts

    Sign up for all blue cross blue shield - arizona policy alerts

    Know when blue cross blue shield - arizona releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Health Choice Arizona's preferred skin substitute products list and prior authorization expectations for providers; applies to providers submitting claims for skin substitute products under the Health Choice Arizona / Blue Cross Blue Shield - Arizona arrangement.

    Policy Summary
    Payerblue cross blue shield - arizona
    PolicyPreferred skin substitute products (coverage and prior authorization)
    Policy CodePolicy N/A
    Change TypePolicy designation / preferred product list
    Effective Date10/01/2021
    Next Review DateN/A
    Key ActionObtain prior authorization for any listed skin substitute product and include supporting documentation when requesting a non-preferred product explaining why a preferred product is not an option.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    15+listed preferred product codes/names

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    10/01/2021effective date
    other productsnon-preferred after date

    Coverage Criteria

    Coverage for preferred products

    Covered when ALL of the following are met

    Preferred product use and PA: Product is one of the listed preferred skin substitute products AND prior authorization has been obtained

    Preferred products require prior authorization; see Health Choice prior authorization guidelines

    Coverage for non-preferred products (exception basis)

    Covered when ALL of the following are met

    Non-preferred product use with justification and PA: Product is not on the preferred list AND documentation explains why a preferred product is not an option AND prior authorization has been obtained

    All skin substitute products not listed as preferred will be considered non-preferred effective 10/1/2021; non-preferred requests must include supporting documentation

    All skin substitute products not included in the list of preferred products will be designated non-preferred effective 10/01/2021. The preferred product list (effective 10/1/2021) and examples of included HCPCS/Q‑codes are published in the notice of preferred skin substitute products.

    Use of a non-preferred skin substitute product may result in claim denial unless the provider submits supporting documentation explaining why a preferred product is not an appropriate option and obtains prior authorization per Health Choice guidelines.

    Coding — Preferred Codes

    Preferred HCPCS/Q codesHCPCSCovered
    Q4100Skin substitute Not Otherwise Specified (for SomaGen only)
    Q4101Apligraf, per sq cm
    Q4105Integra dermal regeneration template (DRT) or Integra Omnigraft dermal regeneration matrix, per sq cm
    Q4106Dermagraft, per sq cm
    Q4110PriMatrix, per sq cm (PriMatrix AG and variants)
    Q4121TheraSkin, per sq cm
    Q4128FlexHD, AllopatchHD, or Matrix HD, per sq cm
    Q4137AmnioExcel, AmnioExcel Plus or BioDExcel, per sq
    Q4151AmnioBand or Guardian, per sq cm
    Q4158Kerecis Omega3, per sq cm
    1–10 of 13
    1/2

    Provider Actions and Requirements

    Prior Authorization

    Prior authorization required for all listed products

    All listed skin substitute products require prior authorization. Requests for non-preferred products also require supporting documentation explaining why preferred products are not an option.

    • Obtain Health Choice Arizona prior authorization before submitting claims for any listed skin substitute product.
    • For non-preferred products, include documentation that explains why a preferred product is not an option.
    Note

    Follow HCA prior authorization submission process

    Providers must follow the Health Choice Arizona prior authorization process and submit requests using the PA Guidelines and PA Grids available on the Health Choice websites.

    • Use the Health Choice Arizona Provider tab PA Guidelines and PA Grids to determine submission requirements.
    • Links: HCA Provider Tab -> PA Guidelines; HCP Provider Tab -> Provider Information.

    Definitions

    Preferred skin substitute products
    Q4100Skin substitute Not Otherwise Specified (for SomaGen only)
    Q4101Apligraf, per sq cm
    Q4105Integra dermal regeneration template (DRT) or Integra Omnigraft dermal regeneration matrix, per sq cm
    Q4106Dermagraft, per sq cm
    Q4110PriMatrix (including PriMatrix AG and variants), per sq cm
    Q4121TheraSkin, per sq cm
    Q4128FlexHD, AllopatchHD, or Matrix HD, per sq cm

    Background

    This notice identifies which skin substitute products Health Choice Arizona designates as preferred for coverage effective 10/01/2021. The notice specifies the covered HCPCS/Q‑codes and trade names (for example, Q4101 Apligraf; Q4106 Dermagraft; Q4121 TheraSkin; Q4158 Kerecis Omega3; etc.). Any skin substitute products not on that published list are considered non-preferred beginning 10/01/2021 and require supporting documentation and prior authorization for coverage consideration.

    Policy Summary
    Payerblue cross blue shield - arizona
    PolicyPreferred skin substitute products (coverage and prior authorization)
    Policy CodePolicy N/A
    Change TypePolicy designation / preferred product list
    Effective Date10/01/2021
    Next Review DateN/A
    Key ActionObtain prior authorization for any listed skin substitute product and include supporting documentation when requesting a non-preferred product explaining why a preferred product is not an option.
    SourceLink
    On This Page
    Coverage CriteriaCoding — Preferred CodesProvider Actions and RequirementsDefinitionsBackground
    Documentation Required

    Include justification for non-preferred product requests

    Documentation supporting why a preferred product is not an option must accompany requests for non-preferred products.

    • Include clinical justification and any relevant prior attempts with preferred products when submitting a non-preferred product request.
    Denial Risk

    Risk of denial for non-preferred products without PA and justification

    Use of a non-preferred skin substitute product will require documentation justifying why a preferred product is not an option; non-preferred products may be denied without that documentation and prior authorization.

    • Effective 10/1/2021, all skin substitute products not listed as preferred will be considered non-preferred.
    • Non-preferred product requests are at risk of denial if prior authorization and supporting documentation are not provided.
    Q4137
    AmnioExcel, AmnioExcel Plus or BioDExcel, per sq
    Q4151AmnioBand or Guardian, per sq cm
    Q4158Kerecis Omega3, per sq cm
    Q4166Cytal, per sq cm
    Q4168AmnioBand, 1 mg
    Q4197PuraPly XT, per sq cm
    Non-preferred skin substitute products — definition and justification requirements
    DefinitionNon-preferred skin substitute products = any skin substitute products not included in the preferred list effective 10/1/2021.
    Coverage pathwayCovered only as an exception when documentation explains why a preferred product is not an option AND prior authorization has been obtained.
    Provider requirementRequests for non-preferred products must include supporting documentation justifying medical need for the non-preferred product.
    Risk of denialUse of a non-preferred product may be denied absent the required justification and prior authorization.
    ReferenceEffective date: 10/1/2021 — all other skin substitute products will be considered non-preferred.